Bank Of India Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Of India Indonesia Tbk. trades at Rp1,250 (market cap 4.56T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 33.1K 24h volume). The key difference: Bank Of India Indonesia Tbk. is far larger — about 27.2× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| BSWD | OBAT | |
|---|---|---|
Market Cap | 4.56T | 167.37B |
Indicative Equilibrium Price | 1,375 | 246 |
Indicative Equilibrium Volume | 5 | 2.4K |
Volume | — | 33.1K |
Lot | — | 331 |
Turnover | — | 8.17M |
Average Price | — | 246.91 |
Value | — | 8.17M |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank of India Indonesia Tbk (formerly PT Bank Swadesi Tbk) was established based on notarial deed No. 20 dated September 28, 1968 of Njoo Sioe Liep, S.H., notary in Surabaya, under the name of PT Bank Pasar Swadesi. Officially operate as general banking on September 2nd 1989. On 1992 the corporate began the money changer business. And on November 11th 1994 the corporate officially operated as foreign exchange bank.
Read more on BSWD →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →